{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T05:02:39Z","timestamp":1785819759051,"version":"3.56.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015993","name":"Kowa Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015993","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL136431"],"award-info":[{"award-number":["R01HL136431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL141917"],"award-info":[{"award-number":["R01HL141917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL147095"],"award-info":[{"award-number":["R01HL147095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Vascular calcification is a cardiovascular disorder with no therapeutic options. We recently reported that <jats:italic>o<\/jats:italic>-octanoyltransferase (CROT) suppression can inhibit vascular calcification <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> through amelioration of mitochondrial function and fatty acid metabolism. Inhibiting calcification with a small molecule compound targeting CROT-associated mechanisms will be a promising non-invasive treatment of vascular calcification. Here we used a computational approach to search for existing drugs that can inhibit vascular calcification through the CROT pathway. For screening of the compounds that reduce CROT expression, we utilized the Connectivity Map encompassing the L1000 computational platform that contains transcription profiles of various cell lines and perturbagens including small molecules. Small molecules (<jats:italic>n<\/jats:italic> = 13) were identified and tested in human primary smooth muscle cells cultured in osteogenic media to induce calcification. Niclosamide, an FDA-improved anthelmintic drug, markedly inhibited calcification along with reduced alkaline phosphatase activity and <jats:italic>CROT<\/jats:italic> mRNA expression. To validate this compound <jats:italic>in vivo<\/jats:italic>, LDL receptor (<jats:italic>Ldlr<\/jats:italic>)-deficient mice fed a high fat diet were given oral doses of niclosamide (0 or 750 ppm admixed with diet) for 10 weeks. Niclosamide treatment decreased aortic and carotid artery calcification as determined by optical near infrared molecular imaging (OsteoSense680) and histological analysis. In addition, niclosamide improved features of fatty liver, including decreased cholesterol levels along with decreased Crot expression, while plasma total cholesterol levels did not change. Proteomic analysis of aortic samples demonstrated that niclosamide affected wingless\/integrated (Wnt) signaling pathway and decreased runt-related transcription factor 2 (Runx2) expression, an essential factor for calcification. Our target discovery strategy using a genetic perturbation database with existing drugs identified niclosamide, that in turn inhibited calcification <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, indicating its potential for the treatment of vascular calcification.<\/jats:p>","DOI":"10.3389\/fcvm.2021.826529","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T06:17:51Z","timestamp":1642659471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Computational Screening Strategy for Drug Repurposing Identified Niclosamide as Inhibitor of Vascular Calcification"],"prefix":"10.3389","volume":"8","author":[{"given":"Takeshi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaharu","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehito","family":"Okui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha A.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.3390\/ijms21082685","article-title":"Vascular calcification-new insights into its mechanism","volume":"21","author":"Lee","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ijcard.2015.08.172","article-title":"Worldwide disparities in cardiovascular disease: challenges and solutions","volume":"202","author":"Okwuosa","year":"2015","journal-title":"Int J Cardiol. (2016)."},{"key":"B3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.tem.2019.06.001","article-title":"Interactive and multifactorial mechanisms of calcific vascular and valvular disease","volume":"30","author":"Demer","year":"2019","journal-title":"Trends Endocrinol Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/ATVBAHA.120.315007","article-title":"CROT (Carnitine O-Octanoyltransferase) is a novel contributing factor in vascular calcification via promoting fatty acid metabolism and mitochondrial dysfunction","volume":"41","author":"Okui","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"B6","volume-title":"Roundtable on Translating Genomic-Based Research for Health (Board on Health Sciences Policy) Institute of Medicine in Drug Repurposing and Repositioning: Workshop Summary.","author":"Johnson","year":"2014"},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug-disease relationships for computational drug repositioning","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief Bioinform."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell."},{"key":"B11","first-page":"265","article-title":"Diagnosis and treatment of intestinal helminths. I. Common intestinal cestodes","volume":"1","author":"Tanowitz","year":"1993","journal-title":"Gastroenterologist."},{"key":"B12","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.exppara.2007.12.001","article-title":"In vitro trypanocidal activity of the anti-helminthic drug niclosamide.","volume":"118","author":"Merschjohann","year":"2008","journal-title":"Exp Parasitol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e007405","DOI":"10.1161\/JAHA.117.007405","article-title":"Deletion of I\u03baB-Kinase \u03b2 in smooth muscle cells induces vascular calcification through \u03b2-catenin-runt-related transcription factor 2 signaling","volume":"7","author":"Al-Huseini","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bbrc.2014.08.007","article-title":"Microtubule stabilization attenuates vascular calcification through the inhibition of osteogenic signaling and matrix vesicle release","volume":"451","author":"Lee","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1172\/JCI80851","article-title":"Sortilin mediates vascular calcification via its recruitment into extracellular vesicles","volume":"126","author":"Goettsch","year":"2016","journal-title":"J Clin Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J Clin Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.3390\/ijms21113904","article-title":"Regulation of Wnt signaling through ubiquitination and deubiquitination in Cancers","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.yexcr.2016.06.007","article-title":"WNT\/\u03b2-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression","volume":"345","author":"Cai","year":"2016","journal-title":"Exp Cell Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/en.2017-00850","article-title":"\u03b2-Catenin Directs Long-Chain Fatty Acid Catabolism in the Osteoblasts of Male Mice.","volume":"159","author":"Frey","year":"2018","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1158\/1535-7163.MCT-13-0608","article-title":"Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer","volume":"13","author":"You","year":"2014","journal-title":"Mol Cancer Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-13-0095","article-title":"Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer","volume":"12","author":"Li","year":"2013","journal-title":"Mol Cancer Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17530","DOI":"10.1074\/jbc.M112.359638","article-title":"Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling","volume":"287","author":"Fonseca","year":"2012","journal-title":"J Biol Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","article-title":"Multi-targeted therapy of cancer by niclosamide: a new application for an old drug","volume":"349","author":"Li","year":"2014","journal-title":"Cancer Lett."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e74538","DOI":"10.1371\/journal.pone.0074538","article-title":"Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e29290","DOI":"10.1371\/journal.pone.0029290","article-title":"Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/\u03b2-catenin pathway","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","article-title":"Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations","volume":"71","author":"Osada","year":"2011","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"708470","DOI":"10.3389\/fcvm.2021.708470","article-title":"Wnt signaling in vascular calcification","volume":"8","author":"Bundy","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2174\/157340308785160552","article-title":"Notch signaling in cardiovascular disease and calcification","volume":"4","author":"Rusanescu","year":"2008","journal-title":"Curr Cardiol Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/ATVBAHA.120.314360","article-title":"Macrophages promote aortic valve cell calcification and alter STAT3 splicing","volume":"40","author":"Raddatz","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","article-title":"The role of the wnt\/\u03b2-catenin signaling pathway in formation and maintenance of bone and teeth","volume":"77","author":"Duan","year":"2016","journal-title":"Int J Biochem Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00223-007-9073-6","article-title":"Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a","volume":"81","author":"Mikhaylova","year":"2007","journal-title":"Calcif Tissue Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1159\/000366400","article-title":"Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Rong","year":"2014","journal-title":"Cell Physiol Biochem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"9037","DOI":"10.1074\/jbc.RA119.008094","article-title":"Diet-induced hepatic steatosis abrogates cell-surface LDLR by inducing de novo PCSK9 expression in mice","volume":"294","author":"Lebeau","year":"2019","journal-title":"J Biol Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm.3699","article-title":"Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice","volume":"20","author":"Tao","year":"2014","journal-title":"Nat Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.mehy.2010.07.011","article-title":"Do cytokines induce vascular calcification by the mere stimulation of TNAP activity?","volume":"75","author":"Lencel","year":"2010","journal-title":"Med Hypotheses."},{"key":"B36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/joim.12940","article-title":"Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease","volume":"286","author":"Carracedo","year":"2019","journal-title":"J Intern Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.mayocp.2013.06.025","article-title":"Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals","volume":"88","author":"Chhabra","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"B38","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.ATV.0000258790.35810.02","article-title":"A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome","volume":"27","author":"Hartvigsen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmat4519","article-title":"Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques","volume":"15","author":"Hutcheson","year":"2016","journal-title":"Nat Mater."},{"key":"B40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ydbio.2009.11.030","article-title":"Wnt signaling in heart valve development and osteogenic gene induction","volume":"338","author":"Alfieri","year":"2010","journal-title":"Dev Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fcell.2020.00862","article-title":"The role of Wnt\/\u03b2-catenin pathway mediators in aortic valve stenosis","volume":"8","author":"Khan","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fphar.2019.00051","article-title":"Drug repurposing: the anthelmintics niclosamide and nitazoxanide are potent TMEM16A antagonists that fully bronchodilate airways","volume":"10","author":"Miner","year":"2019","journal-title":"Front Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"118522","DOI":"10.1016\/j.lfs.2020.118522","article-title":"Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer","volume":"262","author":"Wu","year":"2020","journal-title":"Life Sci."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.826529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T06:17:56Z","timestamp":1642659476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.826529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2021.826529"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.826529","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"article-number":"826529"}}